RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 85 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,070,024 | -12.3% | 26,060 | -7.5% | 0.00% | -100.0% |
| Q1 2024 | $1,220,130 | -1.9% | 28,159 | +4.1% | 0.00% | 0.0% |
| Q4 2023 | $1,243,396 | +97.5% | 27,048 | -1.5% | 0.00% | – |
| Q3 2023 | $629,475 | +57.6% | 27,452 | +13.3% | 0.00% | – |
| Q2 2023 | $399,471 | +296.6% | 24,225 | +329.1% | 0.00% | – |
| Q1 2023 | $100,725 | -38.7% | 5,646 | 0.0% | 0.00% | – |
| Q4 2022 | $164,412 | -93.7% | 5,646 | -97.5% | 0.00% | -100.0% |
| Q1 2022 | $2,616,000 | +879.8% | 227,114 | +748.9% | 0.00% | – |
| Q4 2021 | $267,000 | -23.3% | 26,754 | +0.4% | 0.00% | – |
| Q3 2021 | $348,000 | -40.5% | 26,639 | -10.8% | 0.00% | – |
| Q2 2021 | $585,000 | -29.9% | 29,876 | -23.8% | 0.00% | – |
| Q1 2021 | $834,000 | +7.6% | 39,229 | +50.5% | 0.00% | – |
| Q4 2020 | $775,000 | +85.0% | 26,058 | +34.8% | 0.00% | – |
| Q3 2020 | $419,000 | +4.5% | 19,328 | +7.3% | 0.00% | – |
| Q2 2020 | $401,000 | +152.2% | 18,012 | +72.5% | 0.00% | – |
| Q1 2020 | $159,000 | -67.9% | 10,441 | -51.7% | 0.00% | – |
| Q4 2019 | $495,000 | +243.8% | 21,619 | +222.4% | 0.00% | – |
| Q3 2019 | $144,000 | -48.9% | 6,705 | -48.1% | 0.00% | – |
| Q2 2019 | $282,000 | +9.3% | 12,913 | +36.1% | 0.00% | – |
| Q1 2019 | $258,000 | +98.5% | 9,485 | +94.8% | 0.00% | – |
| Q4 2018 | $130,000 | -97.8% | 4,869 | -97.6% | 0.00% | -100.0% |
| Q3 2018 | $5,799,000 | +82.6% | 198,848 | +95.6% | 0.00% | +100.0% |
| Q2 2018 | $3,176,000 | +1405.2% | 101,648 | +854.6% | 0.00% | – |
| Q1 2018 | $211,000 | -61.1% | 10,648 | -43.2% | 0.00% | – |
| Q4 2017 | $542,000 | – | 18,733 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 735,000 | $13,112,400 | 3.93% |
| NEA Management Company, LLC | 2,909,956 | $51,913,615 | 3.59% |
| Frazier Life Sciences Management, L.P. | 2,164,739 | $38,618,944 | 2.80% |
| RA Capital Management | 5,516,067 | $98,406,635 | 2.23% |
| Samsara BioCapital, LLC | 345,293 | $6,160,027 | 1.27% |
| Rock Springs Capital Management LP | 1,597,123 | $28,492,674 | 0.68% |
| Baker Brothers Advisors | 6,498,267 | $115,929,083 | 0.63% |
| HighVista Strategies LLC | 35,478 | $632,928 | 0.52% |
| Nan Fung Group Holdings Ltd | 32,520 | $580,157 | 0.40% |
| GREAT POINT PARTNERS LLC | 97,544 | $1,740,185 | 0.34% |